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Computational models of audition typically include a
bank of filters and a population of neurons. For exam-
ple, the inner ear is often modeled as the Gammatone
filterbank followed by an ensemble of Integrate-and-Fire
neurons. Alternatively, A1 neurons receive input from
STRFs modeling the selectivity to frequency and ampli-
tude of subcortical neurons. How much information
about sounds is embedded in these models? How much
information is required to maintain intelligibility of nat-
ural and synthetic sound stimuli at various levels of the
auditory system? Is intelligibility maintained in auditory
models based on biological neuron models? In addres-
sing these questions there is a need to evaluate auditory
models not only by computing metrics such as SNR but
by also performing intelligibility tests. Intelligibility is a
speech invariant [1] that reflects the degree of speech
understanding.
Our model consists of a sound stimulus processed by
a Gammatone filterbank or by a multichannel Gabor
STRF. Each channel represents the additive input to a
Hodgkin-Huxley neuron. Unlike Integrate-and-Fire neu-
ron models, conductance-based models exhibit beha-
viors leading to a complex input (stimulus)/output
(spike train) relationship. In order to measure the
amount of information contained in the spike trains, we
derive the best estimate of the original stimulus that
maximizes a quadratic cost functional [2]. While such a
methodology provides a measure of information at var-
ious stages of subcortical or cortical processing, it does
not reveal the degree of intelligibility of sound stimuli
contained in the spike trains. Consequently, we provide
support for the evaluation of the stimulus estimates
based on intelligibility tests.
Furthermore, we formalize intelligibility as an invar-
iant with respect to transformations in the auditory sys-
tem. We estimate the auditory signal at different layers
of the encoding and auditory processing architecture.
Estimation error arises from two sources: the intrinsic
deviation in the phase approximation of the Hodgkin-
Huxley neurons and noise due to large scale numerical
evaluations. Intelligibility tests are performed on the
reconstructed speech stimuli. We find that a small sub-
set of neurons lacks the collective firing frequency
needed to encapsulate a high degree of intelligibility of
typical auditory scenes, whereas a large population of
neurons approximately yields the original sound.
This work establishes that models of the auditory sys-
tem that exhibit a sufficiently large population of biologi-
cally plausible neurons and broad filterbank support,
maintain the intelligibility of natural and synthetic sound
stimuli. For weak auditory stimuli, Hodgkin-Huxley neu-
rons encode sounds with approximately the same intel-
ligibility as Integrate-and-Fire neurons and can thereby
be interchangeably used in computational modeling.
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